Literature DB >> 1351741

Antigen binding thermodynamics and antiproliferative effects of chimeric and humanized anti-p185HER2 antibody Fab fragments.

R F Kelley1, M P O'Connell, P Carter, L Presta, C Eigenbrot, M Covarrubias, B Snedecor, J H Bourell, D Vetterlein.   

Abstract

The murine monoclonal antibody 4D5 (anti-p185HER2) inhibits the proliferation of human tumor cells overexpressing p185HER2 in vitro and has been "humanized" [Carter, P., Presta, L., Gorman, C. M., Ridgway, J. B. B., Henner, D., Wong, W.-L. T., Rowland, A. M., Kotts, C., Carver, M. E., & Shepard, H. M. (1992) Proc. Natl. Acad. Sci. U.S.A. (in press)] for use in human cancer therapy. We have determined the antigen binding thermodynamics and the antiproliferative activities of chimeric 4D5 Fab (ch4D5 Fab) fragment and a series of eight humanized Fab (hu4D5 Fab) fragments differing by amino acid substitutions in the framework regions of the variable domains. Fab fragments were expressed by secretion from Escherichia coli and purified from fermentation supernatants by using affinity chromatography on immobilized streptococcal protein G or staphylococcal protein A for ch4D5 and hu4D5, respectively. Circular dichroism spectroscopy indicates correct folding of the E. coli produced Fab, and scanning calorimetry shows a greater stability for hu4D5 (Tm = 82 degrees C) as compared with ch4D5 Fab (Tm = 72 degrees C). KD values for binding to the extracellular domain (ECD) of p185HER2 were determined by using a radioimmunoassay; the delta H and delta Cp for binding were determined by using isothermal titration calorimetry. ch4D5 Fab and one of the humanized variants (hu4D5-8 Fab) bind p185HER2-ECD with comparable affinity (delta G degrees = -13.6 kcal mol-1).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1351741     DOI: 10.1021/bi00139a003

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

1.  Expression studies of catalytic antibodies.

Authors:  H D Ulrich; P A Patten; P L Yang; F E Romesberg; P G Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

2.  Bound water molecules and conformational stabilization help mediate an antigen-antibody association.

Authors:  T N Bhat; G A Bentley; G Boulot; M I Greene; D Tello; W Dall'Acqua; H Souchon; F P Schwarz; R A Mariuzza; R J Poljak
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

3.  Generation of recombinant guinea pig antibody fragments to the human GABAC receptor.

Authors:  Adnan Memic; Veronica V Volgina; Hélène A Gussin; David R Pepperberg; Brian K Kay
Journal:  J Immunol Methods       Date:  2011-02-26       Impact factor: 2.303

4.  Antibody variable region binding by Staphylococcal protein A: thermodynamic analysis and location of the Fv binding site on E-domain.

Authors:  M A Starovasnik; M P O'Connell; W J Fairbrother; R F Kelley
Journal:  Protein Sci       Date:  1999-07       Impact factor: 6.725

5.  Characterization of the native and denatured herceptin by enzyme linked immunosorbent assay and quartz crystal microbalance using a high-affinity single chain fragment variable recombinant antibody.

Authors:  Yuqin Shang; Ray Mernaugh; Xiangqun Zeng
Journal:  Anal Chem       Date:  2012-09-13       Impact factor: 6.986

6.  Influence of affinity and antigen internalization on the uptake and penetration of Anti-HER2 antibodies in solid tumors.

Authors:  Stephen I Rudnick; Jianlong Lou; Calvin C Shaller; Yong Tang; Andres J P Klein-Szanto; Louis M Weiner; James D Marks; Gregory P Adams
Journal:  Cancer Res       Date:  2011-03-15       Impact factor: 12.701

Review 7.  Advances and future directions in the targeting of HER2-positive breast cancer: implications for the future.

Authors:  Ishwaria M Subbiah; Ana Maria Gonzalez-Angulo
Journal:  Curr Treat Options Oncol       Date:  2014-03

8.  Endocytosis and sorting of ErbB2 and the site of action of cancer therapeutics trastuzumab and geldanamycin.

Authors:  Cary D Austin; Ann M De Mazière; Paul I Pisacane; Suzanne M van Dijk; Charles Eigenbrot; Mark X Sliwkowski; Judith Klumperman; Richard H Scheller
Journal:  Mol Biol Cell       Date:  2004-09-22       Impact factor: 4.138

9.  High affinity antigen recognition of the dual specific variants of herceptin is entropy-driven in spite of structural plasticity.

Authors:  Jenny Bostrom; Lauric Haber; Patrick Koenig; Robert F Kelley; Germaine Fuh
Journal:  PLoS One       Date:  2011-04-22       Impact factor: 3.240

10.  A T cell receptor V alpha domain expressed in bacteria: does it dimerize in solution?

Authors:  D Plaksin; S Chacko; P McPhie; A Bax; E A Padlan; D H Margulies
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.